USP Welcomes New Partners to "Fight the Fakes" Campaign - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Welcomes New Partners to "Fight the Fakes" Campaign



As part of an ongoing international effort to battle counterfeit medicines, the US Pharmacopeial Convention (USP) welcomed 11 new organizations as partners in the global “Fight the Fakes” campaign.

“Counterfeit medicines can account for up to 30% of the drug supply in parts of Asia, Africa, and Latin America according to estimates from the World Health Organization (WHO),” said USP CEO Ron Piervincenzi.

Established in 2013, Fight the Fakes is a campaign to raise awareness about the dangers of fake medicines, giving a voice to those who have been personally impacted and sharing the stories of those working to put a stop to this public health threat. The Fight the Fakes initiative now includes 25 healthcare groups, research institutes, foundations, non-profits, and private sector organizations.

Source: USP

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here